Recent News for TGTX - TG Therapeutics, Inc.

Date Title
Sep 20 TG Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
Sep 17 Is TG Therapeutics (NASDAQ:TGTX) Using Debt In A Risky Way?
Sep 12 TG's ublituximab shows favorable long-term safety profile in extension study
Sep 12 The Daily Biotech Pulse: Ardelyx Awaits Ruling On Constipation Drug, Double Dose Of Good News For Roche, Tocagen Flunks Brain Cancer Study
Sep 12 TG Therapeutics Presents Data for Ublituximab at the 35th Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Sep 8 The Week Ahead In Biotech: Conference Presentations, IPO News Flow Take The Spotlight
Aug 30 TG Therapeutics files for mixed shelf
Aug 29 TG Therapeutics Announces Data Presentations at the Upcoming 35th Annual Congress of ECTRIMS 
Aug 26 TG Therapeutics Mourns the Loss of Board Member, Mark Schoenebaum, MD
Aug 12 Large Option Trader Sells TG Therapeutics Calls After Big Run
Aug 12 Edited Transcript of TGTX earnings conference call or presentation 9-Aug-19 12:30pm GMT
Aug 12 What Kind Of Shareholder Owns Most TG Therapeutics, Inc. (NASDAQ:TGTX) Stock?
Aug 9 TG Therapeutics Inc (TGTX) Q2 2019 Earnings Call Transcript
Aug 9 TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q2 2019 Results - Earnings Call Transcript
Aug 9 TG Therapeutics net loss improves in Q2
Aug 9 TG Therapeutics EPS beats by $0.02, revenue in-line
Aug 9 TG Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results
Aug 9 The Daily Biotech Pulse: Vascepa Delay Sends Amarin Reeling, Eidos Jumps On Buyout Offer, Nektar's Bitter Q2
Aug 7 TG Therapeutics to Host Conference Call on Second Quarter 2019 Financial Results and Business Update
Aug 3 29 Healthcare Stocks Moving In Friday's After-Market Session
Jul 31 Steven Cohen Charges Into Chiasma
Jul 5 Here’s What Hedge Fund Think About TG Therapeutics Inc (TGTX)
Jul 2 TG Therapeutics Announces Presentation of Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis During an Oral Session at the 5th Congress of the European Academy of Neurology
Jul 1 Weekly CEO Buys Highlight
Jun 27 Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Balance Sheet Strong Enough To Weather A Storm?
Back to the Main TGTX Page...